Part of the reluctance to reimburse for telemedicine is that policy makers aren’t aware of the wide range of evidence that currently exists and supports increasing reimbursement for telemedicine, said Kristen McGovern, JD, partner at Sirona Strategies.
Part of the reluctance to reimburse for telemedicine is that policy makers aren’t aware of the wide range of evidence that currently exists and supports increasing reimbursement for telemedicine, said Kristen McGovern, JD, partner at Sirona Strategies.
Transcript (slightly modified)
What has been the reluctance to increase reimbursement for telemedicine?
Telemedicine, I think, in the minds of policy makers has really traditionally been a rural issue. When it made its way into the Medicare reimbursement regulations, it was really to increase access to care in rural areas. Over the past few years, obviously technology has far advanced and now all Americans, a lot of people carry around smartphones or have computers, and they have the ability to access care in different ways. And so it’s no longer a rural issue. It’s really an issue for everyone.
I think the reluctance around reimbursement has been primarily around, you know in the Medicare space there’s a lot of questions about whether seniors, how technology proficient they are and whether they would be able to actually use the technology. There’s also questions about utilization and whether we’re going to blow the budget by giving patients this easy, convenient access to care. And then there’s also questions about research. Policy makers like to have a wide body of evidence before they make any decisions and we do believe that we have a significant body of research. So, it’s just educating people about the telemedicine work that’s already been done and that there is a body of evidence out there that can support increased reimbursement.
Do you believe the idea that senior citizens do not understand how to use telemedicine is an outdated concern?
We are seeing that seniors are much more tech-savvy and if they aren’t, then a lot of times they have a caregiver who is. Generally, the caregiver is a child or someone in their family who’s a little bit younger who may be more experienced with technology and if they don’t know how to use it, can help them use it.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More